ES2115308T3 - Lactonas con actividad antioxidante e hipolipidemica, utiles en la terapia de la aterosclerosis. - Google Patents
Lactonas con actividad antioxidante e hipolipidemica, utiles en la terapia de la aterosclerosis.Info
- Publication number
- ES2115308T3 ES2115308T3 ES95118629T ES95118629T ES2115308T3 ES 2115308 T3 ES2115308 T3 ES 2115308T3 ES 95118629 T ES95118629 T ES 95118629T ES 95118629 T ES95118629 T ES 95118629T ES 2115308 T3 ES2115308 T3 ES 2115308T3
- Authority
- ES
- Spain
- Prior art keywords
- lactones
- antioxidant
- useful
- atherosclerosis
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 201000001320 Atherosclerosis Diseases 0.000 title abstract 3
- 239000003963 antioxidant agent Substances 0.000 title abstract 2
- 230000003078 antioxidant effect Effects 0.000 title abstract 2
- 230000000055 hyoplipidemic effect Effects 0.000 title abstract 2
- 150000002596 lactones Chemical class 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 5
- 230000002093 peripheral effect Effects 0.000 abstract 4
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract 2
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract 2
- 230000001590 oxidative effect Effects 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
Abstract
LACTONAS DE FORMULA Y SUS SALES FARMACOLOGICAMENTE ACEPTABLES DOTADAS CON PROPIEDADES ANTIOXIDANTES E HIPOLIPIDEMICAS Y QUE MUESTRAN LA CAPACIDAD DE PREVENIR Y/O RETARDAR LA MODIFICACION OXIDANTE DE LAS LIPOPROTEINAS MEDIANTE LA COMPETICION CON LA CADENA DE PROPAGACION DE PEROXIDACION POR MEDIO DE UN PURIFICADOR EFECTIVO DE LOS RADICALES PEROXILICOS. LOS DERIVADOS OBJETO DE LA PRESENTE INVENCION SON UTILES EN EL TRATAMIENTO DE LA ATEROSCLEROSIS Y DE MUCHAS PATOLOGIAS VASCULARES RELACIONADAS, COMO CARDIOPATIAS ISQUEMICAS (ANGINA DE PECHO E INFARTO DE MIOCARDIO), TROMBOSIS CEREBRAL Y ARTERIOPATIAS PERIFERICAS, YA QUE DEBIDO A LOS ALTOS NIVELES DE PLASMA DE LOS LIPIDOS Y A LAS MODIFICACIONES OXIDANTES DE LAS LIPOPROTEINAS DE BAJA DENSIDAD (LDL) REPRESENTAN SUCESOS CRUCIALES EN LA PATOGENESIS DE LA ATEROSCLEROSIS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBO940562A IT1274355B (it) | 1994-12-21 | 1994-12-21 | Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2115308T3 true ES2115308T3 (es) | 1998-06-16 |
Family
ID=11340165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95118629T Expired - Lifetime ES2115308T3 (es) | 1994-12-21 | 1995-11-27 | Lactonas con actividad antioxidante e hipolipidemica, utiles en la terapia de la aterosclerosis. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5608084A (es) |
EP (1) | EP0718295B1 (es) |
JP (1) | JP2820652B2 (es) |
AT (1) | ATE165354T1 (es) |
DE (1) | DE69502168T2 (es) |
DK (1) | DK0718295T3 (es) |
ES (1) | ES2115308T3 (es) |
GR (1) | GR3026702T3 (es) |
IT (1) | IT1274355B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6680340B2 (en) * | 2000-08-21 | 2004-01-20 | Merck & Co., Inc. | Anti-hypercholesterolemic drug combination |
DE10261067A1 (de) * | 2002-12-24 | 2004-08-05 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3674836A (en) * | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
US4665091A (en) * | 1985-11-04 | 1987-05-12 | Merck & Co., Inc. | Macrocyclic lactone HMG-CoA reductase inhibitors |
US5196447A (en) * | 1991-08-08 | 1993-03-23 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting On Behalf Of Arizona State University | Neristatin 1 |
-
1994
- 1994-12-21 IT ITBO940562A patent/IT1274355B/it active IP Right Grant
-
1995
- 1995-11-13 US US08/556,648 patent/US5608084A/en not_active Expired - Fee Related
- 1995-11-27 EP EP95118629A patent/EP0718295B1/en not_active Expired - Lifetime
- 1995-11-27 DK DK95118629T patent/DK0718295T3/da active
- 1995-11-27 DE DE69502168T patent/DE69502168T2/de not_active Expired - Fee Related
- 1995-11-27 AT AT95118629T patent/ATE165354T1/de not_active IP Right Cessation
- 1995-11-27 ES ES95118629T patent/ES2115308T3/es not_active Expired - Lifetime
- 1995-12-20 JP JP7332407A patent/JP2820652B2/ja not_active Expired - Lifetime
-
1998
- 1998-04-23 GR GR980400836T patent/GR3026702T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH08231535A (ja) | 1996-09-10 |
IT1274355B (it) | 1997-07-17 |
GR3026702T3 (en) | 1998-07-31 |
EP0718295B1 (en) | 1998-04-22 |
US5608084A (en) | 1997-03-04 |
EP0718295A1 (en) | 1996-06-26 |
DE69502168D1 (de) | 1998-05-28 |
JP2820652B2 (ja) | 1998-11-05 |
DK0718295T3 (da) | 1999-01-11 |
DE69502168T2 (de) | 1998-08-13 |
ATE165354T1 (de) | 1998-05-15 |
ITBO940562A1 (it) | 1996-06-21 |
ITBO940562A0 (it) | 1994-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
CY1106107T1 (el) | Φαρμακολογικες μορφοποιησεις που πepιλαμβανουν ρεσβepατρολη και χρηση αυτων | |
UY26883A1 (es) | Combinación terapéutica | |
UY27092A1 (es) | Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen | |
AR035533A1 (es) | Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la | |
ES2152222T3 (es) | Sulfonamidas, su preparacion y su uso como medicamento e intermedio. | |
ATE469674T1 (de) | 5-aminolävulinsäure-derivate zur behandlung von akne | |
ES2063011T3 (es) | Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente. | |
ES2182888T3 (es) | Inhibidores de la sintesis de los acidos grasos como agentes antimicrobianos. | |
CR7362A (es) | Formulaciones farmaceuticas de derivado de platino | |
DK1390378T3 (da) | Farmaceutisk aktive uridin estere | |
ES2181993T3 (es) | Composiciones para el cuidado de la piel que contienen retinol o ester de retinilo. | |
EE200200625A (et) | Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena | |
PA8525401A1 (es) | Compuestos farmaceuticos | |
BR0013935A (pt) | IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos | |
ES2253378T3 (es) | Extractos de espermatofitos con actividad antineoplasica. | |
ES2166577T3 (es) | Acidos 6- y 7-aminotetrahidroisoquinolin-carboxilicos sustituidos. | |
MX9400630A (es) | 6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida como un agente analgesico y antiinflamatorio. | |
ES2151716T3 (es) | Derivados peptidos. | |
PA8581201A1 (es) | Nuevos derivados de tiazol | |
ES2115308T3 (es) | Lactonas con actividad antioxidante e hipolipidemica, utiles en la terapia de la aterosclerosis. | |
AR028448A1 (es) | Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares | |
ECSP003707A (es) | Diazepanes | |
ES2194157T3 (es) | Composiciones para el cuidado de la piel que contienen un retinoide. | |
PA8531601A1 (es) | Nuevos heteroaromatos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 718295 Country of ref document: ES |